Abstract
Objectives: We evaluated the feasibility of using a precise oral glucose loading combined with subcutaneous insulin administration protocol for 18 F-FDG PET myocardial metabolic imaging in patients with coronary artery disease (CAD) complicated by diabetes mellitus (DM). Methods: 179 consecutive CAD patients complicated by DM were enrolled. Oral glucose was given at variable doses based on baseline blood glucose, and subcutaneous insulin was injected at adjusted doses according to post-load glucose levels before FDG injection. SPECT myocardial perfusion imaging and PET myocardial metabolic imaging were performed using a one-day protocol. The image quality and adverse reaction data were analyzed. Results: Among 179 patients, FDG image quality was scored as excellent in 57.5%, very good in 31.8%, good in 7.8%, fair in 1.7% and non-diagnostic in 1.1%. When patients were stratified by blood glucose level at time of FDG injection >7.77 mmol/L, 5.55–7.77 mmol/L and 7.77 mmol/L had significantly lower odds of excellent image quality ( p = 0.021) than those with 5.55–7.77 mmol/L or p = 0.262). 47 patients (26.3%) exhibited completely viable myocardium, 89 patients (49.7%) had partially viable myocardium, and 43 patients (24.0%) showed nonviable myocardium. None of the patients had severe adverse reactions. Conclusion: The precise oral glucose loading protocol prior to 18 F-FDG injection is feasible for clinical application.

This publication has 26 references indexed in Scilit: